Investor engagement surges as shareholders hold bosses to account on ESG and pay February 2, 2022 Shareholder engagement has skyrocketed in the past year as investors piled into annual general meetings (AGMs) to hold bosses to account on issues like ESG and executive pay, new data has revealed.
M&G backs ‘bioprinter’ firm Nuclera with $10m injection February 2, 2022 Global investment firm M&G has announced it will pump $10m into biotech company Nuclera to accelerate the rollout of the firm's 'bioprinter' technology.
Vodafone ready to go on a deal-making offensive after activist investor pressure February 2, 2022 Vodafone boss Nick Read said the firm is ready to go on a dealmaking offensive as the telecoms giant looks to drive returns for investors following pressure from activist investor Cevian Capital.
Sony raises profit guidance after Spider Man provides a boost February 2, 2022 Sony Group raised its profit guidance for the year by 15 per cent today after third quarter earnings smashed analyst estimates following the success of Spider-Man: No Way Home.
Amazon adds 25,000 workers amid e-commerce boom February 2, 2022 Amazon added 25,000 British workers to its payroll last year as booming demand for e-commerce led to a surge in recruitment at fulfilment and sorting centres.
Klarna clampdown? UK boss Alex Marsh says the time is right for regulation February 2, 2022 Klarna's UK boss tells Charlie Conchie why buy-now pay-later firms need regulation
British Land splashes £157m on London warehouses amid logistics investment boom February 2, 2022 Real estate investment firm British Land has snapped up three warehouses in Wembley as it looks to tap into soaring demand for logistics hubs across London.
Production slumps at Glencore as pandemic strains continue February 2, 2022 Mining giant Glencore reported a slump in production of coal and many of its key metals last year as the pandemic continued to restrict output across its operations.
Private equity giants mull $25bn bid for Novartis generics arm February 1, 2022 Two private equity giants are reportedly discussing launching a joint bid for the generics unit of pharma giant Novartis, according to reports.
Financial SaaS firm OpenGamma closes $21m funding round to ramp up growth February 1, 2022 Financial software-as-a-service firm OpenGamma has closed a $21m funding round as it readies to ramp up growth plans.
